# Axcelis Technologies Inc: Form 10-Q for the period ended Mar 31, 2016

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2016-05-05
- Accepted by EDGAR: May 5, 2016, 12:02 ET
- Period: 2016-03-31
- Accession: 0001104659-16-118129
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465916118129/a16-6510_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465916118129/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2016-01-01 to 2016-03-31 | $67.5m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2016-01-01 to 2016-03-31 | $44.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2016-01-01 to 2016-03-31 | $23.4m | us-gaap:GrossProfit |
| Research and development | 3 months, 2016-01-01 to 2016-03-31 | $8.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2016-01-01 to 2016-03-31 | $2.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2016-01-01 to 2016-03-31 | $1.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2016-01-01 to 2016-03-31 | −$504.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2016-01-01 to 2016-03-31 | $1.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2016-01-01 to 2016-03-31 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2016-01-01 to 2016-03-31 | $0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2016-01-01 to 2016-03-31 | 122,078,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2016-01-01 to 2016-03-31 | −$10.2m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2016-01-01 to 2016-03-31 | $1.3m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2016-03-31 | $67.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-03-31 | $236.3m | us-gaap:AssetsCurrent |
| Total assets | at 2016-03-31 | $293.3m | us-gaap:Assets |
| Current liabilities | at 2016-03-31 | $45.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-03-31 | $99.0m | us-gaap:Liabilities |
| Shareholders' equity | at 2016-03-31 | $194.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 20,314 characters.

*Certain statements in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” are forward-looking statements that involve risks and uncertainties. Words such as may, will, should, would, anticipates, expects, intends, plans, believes, seeks, estimates and similar expressions identify such forward-looking statements. The forward-looking statements contained herein are based on current expectations and entail various risks and uncertainties that could cause actual results to differ materially from those expressed in such forward-looking statements. Factors that might cause such a difference include, among other things, those set forth under “Liquidity and Capital Resources” and under “Risk Factors” in Part II, Item 1A to our annual report on Form 10-K for the year ended December 31, 2015, which discussion is incorporated herein by reference. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date hereof. We assume no obligation to update these forward-looking statements to reflect actual results or changes in factors or assumptions affecting forward-looking statements, except as may be required by law.*

### Overview

Axcelis is a worldwide producer of ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, the Company provides extensive aftermarket service and support, including spare parts, equipment upgrades and maintenance services to the semiconductor industry worldwide. Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our net revenue from our ten largest customers accounted for 79.6% of total revenue for the three months ended March 31, 2016.

Our product development and manufacturing activities occur primarily in the United States. Axcelis’ equipment and service products are highly technical and are sold primarily through a direct sales force in the United States, Europe and Asia.

Demand for semiconductor manufacturing equipment and services has historically been subject to cyclical industry conditions reflecting our customers’ responses to changes in the nature and timing of technological advances in fabrication processes, supply and demand for chips, and global economic and market conditions.

Separately from overall market demand, Axcelis’ results are also impacted by our customers’ decisions to purchase our products rather than our competitors’ systems. Since 2014, our financial results reflect increasing sales of our innovative Purion ion implantation systems, and our continued investment in research and development programs related to our Purion ion implantation products. We expect to continue to grow Purion system sales and maintain control of our cost structure.

In light of these conditions, Axcelis’ results can vary significantly year-over-year, as well as quarter-over-quarter.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations included herein and in our Annual Report on Form 10-K for the year ended December 31, 2015 are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2015.

### Results of Operations

The following table sets forth our results of operations as a percentage of total revenue:

| Revenue: | Three months ended March 31, 2016 | 2015 |
| --- | ---: | ---: |
| Product | 92.1% | 92.1% |
| Services | 7.9 | 7.9 |
| Total revenue | 100.0 | 100.0 |
| Cost of revenue: |  |  |
| Product | 59.6 | 61.7 |
| Services | 5.7 | 6.4 |
| Total cost of revenue | 65.3 | 68.1 |
| Gross profit | 34.7 | 31.9 |
| Operating expenses: |  |  |
| Research and development | 12.8 | 11.2 |
| Sales and marketing | 8.8 | 7.7 |
| General and administrative | 8.9 | 8.3 |
| Restructuring charges | 0.4 | — |
| Total operating expenses | 30.9 | 27.2 |
| Income from operations | 3.8 | 4.7 |
| Other (expense) income: |  |  |
| Interest income | 0.1 | — |
| Interest expense | (1.6) | (1.4) |
| Other, net | (0.1) | (0.6) |
| Total other (expense) income | (1.6) | (2.0) |
| Income before income taxes | 2.2 | 2.7 |
| Income tax (benefit) provision | (0.7) | 0.1 |
| Net income | 2.9% | 2.6% |

### Revenue

The following table sets forth our revenue.

*(dollars in thousands)*

| Revenue: | Three months ended March 31, 2016 | 2015 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $62,175 | $67,530 | $(5,355) | (7.9)% |
| Percentage of revenue | 92.1% | 92.1% |  |  |
| Services | 5,346 | 5,753 | (407) | (7.1)% |
| Percentage of revenue | 7.9% | 7.9% |  |  |
| Total revenue | $67,521 | $73,283 | $(5,762) | (7.9)% |

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

#### Product

Product revenue which includes system sales, sales of spare parts, product upgrades and used systems was $62.2 million, or 92.1% of revenue during the three months ended March 31, 2016, compared with $67.5 million, or 92.1% of revenue for the three months ended March 31, 2015. The $5.4 million decrease in product revenue for the three months ended March 31, 2016 was primarily driven by a decrease in the number of Purion systems sold compared to the three months ended March 31, 2015.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at March 31, 2016 and December 31, 2015 was $8.8 million and $8.5 million, respectively. The increase is due to the timing of the acceptance of deferred system sales.

#### Services

Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $5.3 million, or 7.9% of revenue for the three months ended March 31, 2016, compared with $5.8 million, or 7.9%, of revenue for the three months ended March 31, 2015. Although services revenue typically increases with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.

### Revenue Categories used by Management

As an alternative to the line item revenue categories discussed above, management also uses revenue categorizations which look at revenue by systems and aftermarket as described below.

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

#### Systems

Included in total revenue of $67.5 million during the three months ended March 31, 2016 is revenue from sales of new systems of $37.0 million, or 54.8% of total revenue, compared with $42.5 million, or 58.0%, of total revenue for the three months ended March 31, 2015. The decrease was due to lower unit sales of our Purion systems in the three months ended March 31, 2016 compared to the prior year period.

#### Aftermarket

We refer to the business of selling spare parts, product upgrades and used systems, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business. Included in total revenue of $67.5 million during the three months ended March 31, 2016 is revenue from our aftermarket business of $30.5 million, compared to $30.8 million for the three months ended March 31, 2015. Aftermarket revenue generally increases with the expansion of the installed base of systems, but can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities which affects the sale of spare parts and demand for equipment service.

### Gross Profit / Gross Margin

The following table sets forth our gross profit / gross margin.

*(dollars in thousands)*

| Gross Profit: | Three months ended March 31, 2016 | 2015 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Product | $21,912 | $22,345 | $(433) | (1.9)% |
| Product gross margin | 35.2% | 33.1% |  |  |
| Services | 1,504 | 1,035 | 469 | 45.3% |
| Services gross margin | 28.1% | 18.0% |  |  |
| Total gross profit | $23,416 | $23,380 | $36 | 0.2% |
| Gross margin | 34.7% | 31.9% |  |  |

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

#### Product

Gross margin from product revenue was 35.2% for the three months ended March 31, 2016, compared to 33.1% for the three months ended March 31, 2015. The increase in gross margin of 2.1 percentage points resulted from the net effect of higher gross margins on systems sales partially offset by lower gross margins on parts and upgrade revenue.

#### Services

Gross margin from services revenue was 28.1% for the three months ended March 31, 2016, compared to 18.0% for the three months ended March 31, 2015. The increase in gross margin is attributable to changes in the mix of service contracts and lower overall service costs.

### Operating Expenses

The following table sets forth our operating expenses:

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-Period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $8,636 | $8,199 | $437 | 5.3% |
| Percentage of revenue | 12.8% | 11.2% |  |  |
| Sales and marketing | 5,960 | 5,628 | 332 | 5.9% |
| Percentage of revenue | 8.8% | 7.7% |  |  |
| General and administrative | 6,042 | 6,101 | (59) | (1.0)% |
| Percentage of revenue | 8.9% | 8.3% |  |  |
| Restructuring charges | 282 | 10 | 272 | 2,720.0% |
| Percentage of revenue | 0.4% | —% |  |  |
| Total operating expenses | $20,920 | $19,938 | $982 | 4.9% |
| Percentage of revenue | 30.9% | 27.2% |  |  |

Our operating expenses consist primarily of personnel costs, including salaries, commissions, bonuses, share-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses. Personnel costs of $11.9 million, are our largest expense, representing 57.7% of our total operating expenses for the three months ended March 31, 2016, as compared to $11.3 million, or 56.5% of total operating expenses for the three months ended March 31, 2015.

### Research and Development

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $8,636 | $8,199 | $437 | 5.3% |
| Percentage of revenue | 12.8% | 11.2% |  |  |

Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems, and introducing them at competitive prices on a timely basis. Accordingly, based on our strategic plan, we establish annual R&D budgets to fund programs that we expect will drive competitive advantages.

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

Research and development expense was $8.6 million during the three months ended March 31, 2016; an increase of $0.4 million, or 5.3%, compared with $8.2 million during the three months ended March 31, 2015. The increase was due to higher personnel costs.

### Sales and Marketing

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Sales and marketing | $5,960 | $5,628 | $332 | 5.9% |
| Percentage of revenue | 8.8% | 7.7% |  |  |

Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

Sales and marketing expense was $6.0 million during the three months ended March 31, 2016; an increase of $0.3 million, or 5.9%, compared with $5.6 million during the three months ended March 31, 2015, primarily due to increases in personnel costs, new tool evaluations and freight expenses.

### General and Administrative

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| General and administrative | $6,042 | $6,101 | $(59) | (1.0)% |
| Percentage of revenue | 8.9% | 8.3% |  |  |

Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

General and administrative expense was $6.0 million during the three months ended March 31, 2016; a decrease of less than $0.1 million, or 1.0%, relatively flat when compared with $6.1 million during the three months ended March 31, 2015.

### Restructuring Charges

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges | $282 | $10 | $272 | 2,720.0% |
| Percentage of revenue | 0.4% | —% |  |  |

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

In the three months ended March 31, 2016, due to changes in customer service contracts resulting from a consolidation in our customer base, we had severance and other costs related to a reduction in force. We recorded a minor adjustment to restructuring expense during the three months ended March 31, 2015.

### Other (Expense) Income

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Other (expense) income, net | $(1,052) | $(1,473) | $(421) | (28.6)% |
| Percentage of revenue | 1.6% | 2.0% |  |  |

#### Three Months Ended March 31, 2016 Compared with Three Months Ended March 31, 2015

Other expense was $1.1 million for the three months ended March 31, 2016 compared with other expense of $1.5 million for the three months ended March 31, 2015. Other (expense) income consists primarily of interest expense related to our financing arrangements, including the lease of our corporate headquarters, foreign exchange gains and losses attributable to fluctuations of the U.S. dollar against the local currencies of certain of the countries in which we operate, interest earned on our invested cash balances and bank fees associated with our financing arrangements. The decrease in other expense was primarily driven by the reversal of accrued interest associated with the reversal of a tax reserve.

During the three months ended March 31, 2016 and 2015, respectively, with the exception of the lease agreement entered into by the Company relating to the sale leaseback transaction in the first quarter of 2015, we had no significant off-balance-sheet risks such as exchange contracts, option contracts or other foreign hedging arrangements.

### Income Tax (Benefit) Provision

*(dollars in thousands)*

|  | Three months ended March 31, 2016 | 2015 | Period-to-period change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Income tax (benefit) provision | $(504) | $101 | $(605) | (599.0)% |
| Percentage of revenue | (0.7)% | 0.1% |  |  |

We incur income tax expense relating principally to operating results of foreign entities in Europe and Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain European tax jurisdictions and, as a result, we do not currently pay significant income taxes in those jurisdictions. Additionally, we do not recognize the tax benefit for such losses in the United States and certain European taxing jurisdictions, and will not do so until we have sufficient income such that these tax benefits can be utilized. The Company will continue to maintain a full valuation allowance for these tax assets until sustainable future levels of profitability are evident.

During the first quarter of 2016, the statute of limitations associated with a tax position previously taken by the Company expired. This previously recorded tax reserve of $0.6 million and related accrued interest of $0.3 million were reversed during the three months ended March 31, 2016.

### Liquidity and Capital Resources

Our liquidity is affected by many factors. Some of these relate specifically to the operations of our business, for example, the rate of sale of our products, and others relate to the uncertainties of global economies, including the availability of credit and the condition of the overall semiconductor equipment industry. Our established cost structure, other than cost of goods sold, does not vary significantly with changes in volume. We experience fluctuations in operating results and cash flows depending on these changes in revenue levels.

During the three months ended March 31, 2016, the Company used $10.2 million of cash from operating activities. This was predominately driven by increases in accounts receivable and other assets and liabilities. In comparison, during the three months ended March 31, 2015, the Company generated $8.7 million of cash from operating activities.

Investing activities for the three months ended March 31, 2016 and 2015 included $1.3 million and $0.3 million, respectively, used for capital expenditures.

Financing activities for the three months ended March 31, 2016 provided net cash of $0.3 million, primarily relating to the exercise of stock options. In comparison, financing activities for the three months ended March 31, 2015 provided net cash of $34.9 million, primarily due to a net cash inflow of $48.5 million from the sale and leaseback of our corporate headquarters building in Beverly, Massachusetts. This cash inflow from the sale and leaseback was reduced by $0.8 million of related financing costs and the $14.5 million discharge of a term loan secured by a mortgage on the property. Cash provided by financing activities in the first quarter of 2015 also included $0.9 million received relating to the exercise of stock options and a $0.8 million decrease in our restricted cash balance.

We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash and cash equivalents will be sufficient to satisfy our anticipated cash requirements for at least the next twelve months. We currently have no credit facility but the Company believes it would be able to borrow on reasonable terms if needed.

Management believes that maintaining a strong cash balance is appropriate to fund a potential ramp in business. Should demand for our products decline in future periods, we believe we can align spending levels to provide sufficient liquidity to support operations.

### Commitments and Contingencies

Significant commitments and contingencies at March 31, 2016 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 17 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

## Market risk

As filed, 200 characters.

As of March 31, 2016, there have been no material changes to the quantitative information about market risk disclosed in Item 7A to our Annual Report on Form 10-K for the year ended December 31, 2015.

## Controls and procedures

As filed, 1,033 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the three months ended March 31, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 170 characters.

As of March 31, 2016, there have been no material changes to the risk factors described in Item 1A to our Annual Report on Form 10-K for the year ended December 31, 2015.

Filed May 5, 2016.
Source: SEC EDGAR, the filing index for accession 0001104659-16-118129. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
